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Abstract
Identifying causal relationships for a treatment intervention is a fundamental problem in
health sciences. Randomized controlled trials (RCTs) are considered the gold standard
for identifying causal relationships. However, recent advancements in the theory of causal
inference based on the foundations of structural causal models (SCMs) have allowed the
identification of causal relationships from observational data, under certain assumptions.
Survival analysis provides standard measures, such as the hazard ratio, to quantify the
effects of an intervention. While hazard ratios are widely used in clinical and epidemiolog-
ical studies for RCTs, a principled approach does not exist to compute hazard ratios for
observational studies with SCMs. In this work, we review existing approaches to compute
hazard ratios as well as their causal interpretation, if it exists. We also propose a novel
approach to compute hazard ratios from observational studies using backdoor adjustment
through SCMs and do-calculus. Finally, we evaluate the approach using experimental data
for Ewing’s sarcoma.
1. Introduction
Experimental studies such as randomized controlled trials (RCT) are considered the gold-
standard in hypothesis testing. For safety and efficacy reasons and regulatory purposes,
most new drugs or treatments are studied through RCTs (Greene and Podolsky, 2012).
RCTs provide the best mechanism to identify the causal effect of treatments or interven-
tions, by adjusting for observed and unobserved confounders under the rubric of a potential
outcome framework (Fisher et al., 1960). Despite clear advantages of RCTs in drug-trials, in
c© 2019 R. Adib, P. Griffin, S.I. Ahamed & M. Adibuzzaman.
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Causally Formulated Hazard Ratio Estimation
practice, they are expensive, time-consuming, and not feasible in many cases due to ethical
reasons. Other issues with RCTs include low recruitment rate, loss to follow-up, insufficient
sample size, and being prone to selection bias (Nichol et al., 2010; Frieden, 2017). While
RCTs remain the best way to establish causation, large amounts of data captured with new
technologies during routine healthcare (e.g., electronic health records (EHR) or wearable
devices), colloquially termed big health data, has the potential to discover causal effects
from observational studies to complement RCTs. With proper methodological considera-
tions, observational studies can provide a way to emulate RCTs and go beyond statistical
correlation (Herna´n et al., 2008; Herna´n and Robins, 2017).
In the 1970s, the potential outcome framework was extended to observational studies
to identify causal relationships from observational data through the Rubin Causal Model
(RCM) (Rubin, 1974; Rosenbaum and Rubin, 1983; Holland, 1986). Recent advances in
structural causal model (SCM) provides the methodological framework under the potential
outcome framework for graphically formalizing the identification of causal effects from ob-
servational and experimental data (Pearl, 2009; Pearl et al., 2016). SCMs can be used to
emulate RCTs from observational data in many cases if the graphical model is identifiable
(Bareinboim and Pearl, 2016), which signifies the capability of estimating the interventional
distribution (P (y|do(x))) from the available data with the assumptions incorporated in the
model.
Experimental studies (including RCTs) frequently explore and report survival analysis
measures. Survival analysis is the branch of statistics that analyzes the expected duration
of time-to-event with outcome statistics such as hazard ratio, odds ratio, and risk ratio.
Survival analysis has been well-studied under the potential outcome framework with exper-
imental studies and with RCM for observational studies (Cole and Herna´n, 2004; Herna´n,
2010). Recent research has also studied survival analysis with RCM for observational studies
considering the data generating mechanism or the study designs to estimate outcome statis-
tics such as hazard ratio, odds ratio, risk ratio, and risk difference (Didelez and Sheehan,
2007; Herna´n, 2004).
Commonly reported outcomes from survival analysis in experimental clinical studies
include the survival curve and hazard ratio (HR). The survival curve graphically reports
the hazard in a population and represents the fraction of the population that survived
in the treatment and the control group over time. HR describes the comparative hazard
between the treatment and the control group. Hazard function, or simply hazard signifies
the rate of events-of-interest (e.g., a death) at time t, conditional on survival until time
t and beyond (Spruance et al., 2004). Even though HR is widely used in practice as a
standard tool for comparative evaluation of the outcome between treatment and control
groups, it depends on the length of the study and, by definition, has an inherent selection
bias (since only the survived population at time t are selected at time t + 1) (Herna´n,
2010). In addition, both the survival curve and HR do not consider the study design, that
is RCT versus observational study, in their formalization. Consequently, it is difficult to
interpret the results of an intervention from only the reported hazard ratio (Herna´n, 2010)
and compare different studies with varying study designs and time lengths. The researcher
has to consider the design of the study, length of the study as well has the hazard ratio to
understand the effectiveness of the treatment. Structural causal models (SCMs) provide a
framework to explicitly define the design of the study, the assumptions for the study, as well
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as the length of the study. However, to the best of our knowledge, a framework to compute
the hazard ratio with SCMs does not exist.
Previous approaches for adjusted survival curves under the rubric of RCM used inverse
probability weighting (IPW) to adjust for confounders in the estimand (Cole and Herna´n,
2004). However, this approach has a strong assumption, namely ignorability (Rubin, 1978;
Angrist et al., 1996). The ignorability assumption states that there are no unobserved con-
founders in the model, and the variables considered for IPW satisfy the backdoor criterion.
Although an approach with instrumental variable can be used when the treatment assign-
ment is non-ignorable (Angrist et al., 1996), in practice, this is rather a strong assumption
and a variable can be a mediator, a collider, an M-bias, or a confounder (Lederer et al.,
2019). In this paper, we formulate the estimation of the hazard ratio from observational
studies under the rubric of SCMs that does not depend on the ignorability assumption.
We provide a principled approach to define observational studies using SCMs, redefine
with time-specific survival as outcomes (instead of survival time as the only outcome), and
therefore mathematically transform observational studies to the corresponding experimental
studies by adjusting for confounders with the backdoor criterion and then, sample from the
experimental studies to estimate hazard ratios. We provide the mathematical formalization
of the approach with a simple causal graph and with detailed mathematical derivation,
and validate the results with a simulated data set and a benchmark data set on Ewing’s
sarcoma.
1.1. Clinical Relevance
Most clinical research reports HR with survival analysis. However, the reported HR and
its process of calculation do not take into account the study design (e.g., RCT vs. obser-
vational study) and corresponding assumptions (e.g., ignorability). This makes it harder
to compare the results of different studies with different study designs, sample populations,
study lengths and assumptions. Our proposed method with SCMs estimates HR by explic-
itly describing the study designs and assumptions for a better clinical understanding of the
effect of the treatment of interest.
1.2. Technical Significance
We propose a novel approach to estimate the HR from observational studies with SCM,
taking the causal relationship between treatment and outcome into account. In HR calcu-
lation for survival analysis of observational studies, our review of the literature identifies a
lack of causal interpretation. Our proposed approach first develops a time-invariant causal
model and estimates the survival time after adjusting for the confounders in the SCM using
backdoor adjustment and do-calculus. The development of an SCM enables us to iden-
tify the confounding variables, unlike with the ignorability assumption where we adjust for
every variable available (except treatment and outcome), as well as properly adjust using
the minimal set, thus reducing computational requirements. The computed survival times
are considered “as-if” they were sampled from an RCT. The newly adjusted survival times
are capable of expressing the true causal effect of treatment on the outcome through the
survival curve and HR. We validate the proposed method in both simulated experiments
and with observational data.
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1.3. Generalizable Insights
We propose a novel method of estimating the HR for observational studies under the rubric
of SCMs. The method can be used for any observational studies with survival data, after
defining the SCM. Our method of estimating the HR through SCMs clearly defines the
study-design and assumptions in the model. All the source code for this study is shared
with the research community through a GIT repository. A Python-based library has been
released that takes the data, the graph, and length of the study as input and provides
the adjusted survival curve with backdoor adjustment and the hazard ratio as the output.
Our approach is limited in the cases when i) the SCM is not defined and ii) the SCM is
not identifiable through the adjustment formula or backdoor adjustment (i.e., there is no
backdoor set).
2. Related Work
Survival analysis (Kleinbaum and Klein, 2010) is a methodological approach for modeling
and comparing the time-to-event between two populations. The event is called a hazard,
which can be death, an adverse clinical event, or a mechanical failure for physical systems.
It compares the condition of survival in the treatment versus control group, and reports
outcomes with statistical measures such as the HR. Frequently reported approaches in
survival analysis include Kaplan Meier survival curve, Cox proportional hazards model,
life tables, and survival trees,. We review a non-parametric approach of the Kaplan Meier
survival curve and the semi-parametric approach of the Cox proportional hazards model.
The Kaplan Meier survival curve (Kaplan and Meier, 1958) is a non-parametric statistic
representing the survival function and HR in the treatment and the control group. It
provides a visual comparison between survival functions in different treatment or control
groups; it does not differentiate between RCTs or observational studies. Data from both
of the approaches can be plotted as the Kaplan Meier curve. It is up to the individual
researcher to interpret and explain the Kaplan Meier curve based on the study design. Cox
PH model, on the other hand, is computationally complex. However, it is a commonly used
approach for survival analysis, and is widely used to compute the HR in epidemiological
studies. The key aspect of it is the underlying proportional hazards assumption (Cox, 1972),
stating that the HRs of the treatment and control group are proportional and is a function
of the covariates. It is a semi-parametric model since no assumption is made about the
baseline hazard function (i.e., hazard function with no covariates). In general, it is effective
in estimating both regression coefficients (βi) and the HR (Kleinbaum and Klein, 2010).
Futher, it is unbiased (when estimated considering all possible covariates).
We review existing approaches to compute the HR for observational and experimental
studies. Previous work on survival analysis for observational data with RCM under potential
outcome used IPW to adjust for confounders (Cole and Herna´n, 2004). However, RCM
requires the ignorability assumption that all variables considered for adjustment with IPW
satisfy the backdoor criterion. In reality, a variable can also be a mediator, and in those cases
adjusting for the mediators will result in inaccurate analysis. It has also been shown that the
HR estimation approach has an inherent selection bias (Herna´n et al., 2004; Herna´n, 2010)
as only the patients who survived at time t were sampled at time t + 1 to be considered
for the estimation. SCMs provide the mathematical machinery to identify the backdoor
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variables given a causal graph. We used the same Ewing’s sarcoma data set as studied
in (Cole and Herna´n, 2004) with the same assumptions (i.e., all the covariates satisfy the
backdoor criterion) to arrive at the same result as a validation strategy for our approach.
For survival analysis, it was shown that in some cases the Kaplan Meier curve may
show no difference between the treatment and control groups when in reality there is a
statistically significant difference in the HR, if it is adjusted properly (Makuch, 1982).
The rationale behind this phenomenon is that a non-parametric approach is used to plot
the survival curve, whereas a semi-parametric method is used to calculate the HR. The
authors (Makuch, 1982) presented an approach to construct a plot of the survival curve
consistent with the HR calculated. In this work, the adjusted survival curve for a specific
treatment group was estimated by calculating a mixture of the estimated survival functions
for separate strata, and weighted based on the distribution of the covariate in the sample
dataset. However, the approach does not consider the design of the study in the survival
analysis.
To extend the existing definition of the Cox PH Model, the Marginal Structural Cox
PH Model has been introduced and used to find the effect of Zidovudine on the survival
of HIV-positive men (Herna´n et al., 2000). Statistical analysis in the presence of time-
dependent confounders is commonly done through a standard Cox PH model. However,
Robin (Robins, 1997) has previously shown that this approach cannot adjust for all biases.
Similar to previous work under the RCM, the authors used the conditional ignorability
assumption. This is a much stronger assumption compared to using the SCM to identify
confounding variables opening the backdoor. Several other researchers (Satten and Datta,
2001; Rotnitzky and Robins, 2014) have used the IPW approach, although without using
SCMs.
The existing literature to compute the HR does not consider the study design and
might lead to misinterpretation if the data were not sampled correctly or adjusted for the
right confounding variables. While previous research alludes to this problem, they do not
provide the mathematical machinery for survival analysis. Although the traditional Cox PH
Model can minimize the effects of biases, it is not the same as “adjustment” of confounding
variables. The bias is reduced by fitting the Cox PH regression model until convergence
(Cox, 1972), it does not consider the study design or the data generating mechanism.
The model fitting approach does not generate a causally meaningful interpretation despite
reduction in biases. Our goal is to formulate an approach that estimates the HR through a
causal formulation considering the data generating mechanism with SCM, that portrays the
direct causal effect of treatment on outcome, in terms of the HR metric. The assumption
of variables opening the backdoor path in the SCM as confounders and adjustment on the
dataset based on that enables a more causally interpretable estimation of the HR.
3. Background
3.1. Hazard Ratio
To define the HR, we use the hazard function (Spruance et al., 2004) in the Cox proportional
hazard model:
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h(t,X) = h0(t) exp(
p∑
i=1
βiXi) (1)
Based on this, the Hazard Ratio (HR) is defined (Kleinbaum and Klein, 2010) as:
HR =
h(t,Xx=1)
h(t,Xx=0)
(2)
Here, h(t,X) represents the hazard function at time t and the vector with the covari-
ates of the model X. X can also be written as [w0, w1, ..., wm, z0, z1, ..., zn, x], where x is
the treatment, zi are the confounders, and wi are the other associated covariates. Xx=1
represents the value of the covariate vector X with value of the treatment set as 1 (x = 1),
making Xx=1 = [w0, w1, ..., wm, z0, z1, ..., zn, 1]. β represents the maximum likelihood esti-
mates (MLE) for each covariate. In other words, β is the corresponding coefficient for each
covariate that fits the data into a converging model for the Cox regression.
As expressed in Equation 1, the proportional hazard assumption defines the hazard
function h(t,X) to be composed of the baseline hazard function h0(t) (i.e., hazard when all
covariates are set to 0), multiplied with the exponential of the sum of β multiplied by the
corresponding covariate.
Since we have defined the HR and hazard function, we can simplify the equation of the
HR to:
HR =
h(t,Xx=1)
h(t,Xx=0)
=
h0(t) exp(βx1 + βzZ + ...)
h0(t) exp(βx0 + βzZ + ...)
= exp(βx)
(3)
In other words, the HR is equivalent to the exponential of the regression coefficient β.
However, computing β is non-trivial since, in practice, one does not know the baseline
hazard function (h0(t)). We can only estimate the HR using the maximum likelihood
function, and iterating until the model converges to a pre-defined error bound (Kleinbaum
and Klein, 2010).
Although the HR is an important outcome, it has limitations in explaining causal re-
lationships. No causal mechanism is understood from the HR. This is because the HR is
calculated from the convergence of regression models and, confounding and other such bias
is handled by simply including the covariates to the model. It is then up to the individual
researcher to make sure that the right data are used to measure the HR and interpret ac-
cordingly. For example, an HR calculated from an RCT provides the casually linked hazard
for the intervention, whereas the same HR calculated from an observational study simply
provides a correlated hazard. This existing approach simplifies the calculation and reduces
the burden on the researcher. However, we frequently find differences between the survival
curve and the HR. This difference, or bias, arises because of the inherent definitions of the
survival curve and Cox PH model.
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3.2. Structural Causal Models
Structural causal models (SCMs), developed on the foundations of probabilistic graphical
models, draw inferences that explain the causal relationship between variables. With an
SCM, a causal model is defined first and is expressed with a graphical representation.
Definition 1 gives the formal description of an SCM: (Bareinboim and Pearl, 2016; Pearl,
2009).
Definition 1 (Structural Causal Model) A structural causal model M is a 4-tuple
〈U, V, f, P (u)〉 where:
1. U is a set of background (exogenous) variables that are determined by factors outside
of the model,
2. V is a set {V1, V2, ..., Vn} of observable (endogenous) variables that are determined by
variables in the model (i.e., determined by variables in U ∪ V ),
3. F is a set of functions {f1, f2, ..., fn} such that each fi is a mapping from the respective
domains of Ui∪PAi to Vi, where Ui ⊆ U and PAi ⊆ V Vi and the entire set F forms a
mapping from U to V . In other words, each fi in vi ← fi(pai, ui), i = 1, ..., n, assigns
a value to Vi that depends on the values of the select set of variables (Ui ∪ PAi), and
4. P (u) is a probability distribution over the exogenous variables.
An SCM is often expressed by a causal graph G. Each node V in G represents an
observed or unobserved variable, and each directed edge E represents the causal relation-
ships between them. To find the causal effect of variable X on variable Y , do-calculus is
introduced (Pearl et al., 2016). Do-calculus is used to map the observational reality to the
corresponding experimental reality with the identifiability equation by adjusting for differ-
ent kinds of biases (e.g., confounding bias), if it exists. The backdoor criterion provides a
powerful tool to identify the variables that need to be adjusted for this transformation (in
other words, adjust for confounding bias) and is defined in definitions 2 and 3.
Definition 2 (Backdoor Criterion) Given an ordered pair of variables (X,Y ) in a di-
rected acyclic graph G, a set of variables Z satisfies the backdoor criterion relative to (X,Y )
if no node in Z is a descendant of X, and Z blocks every path between X and Y that contains
an arrow into X.
Definition 3 (Backdoor Adjustment) If a set of variables Z satisfies the back-door cri-
terion relative to (X,Y ), then the causal effect of X on Y is identifiable and is given by the
formula: P (y|do(x)) = ∑z P (y|x, z)P (z)
3.3. Problem Definition
Our research problem is to develop a method to compute the HR for observational studies
by leveraging the SCM by explicitly declaring our assumptions and adjusting for the right
confounders. The goal is to acknowledge the defined roles of variables in the SCM, and
use a minimum set of confounders to adjust for backdoor, thus building a computationally-
efficient and more accurate model for objective estimation and comparison. The algorithm
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will take three sets/inputs, (1) observational dataset D consisting of treatment, outcome in
survival-time and other covariates, (2) SCM supporting the causal mechanism and dataset,
G, and, (3) length-of-trial T . At the completion of the algorithm, the output will be: (1)
adjusted survival curve S (non-parametric estimation), and (2) hazard ratio of treatment,
HR (semi-parametric estimation) (Figure 1). The assumption in our approach is that the
observational data are available, and the SCM is fully specified.
4. Methods
In this section, we formalize our approach to mathematically transform the time-dependent
observational data to the corresponding experimental data by leveraging the SCM. We
then use the adjusted dataset for estimating HR using Cox PH Model. Our proposed
approach focuses on causal effect of treatment on outcome to measure HR. We start with
an observational study scenario and define all related assumptions. The schematic diagram
for the proposed approach is shown in Figure 1.
Figure 1: Schematic overview of the proposed approach. Observational data, corresponding
causal diagram and the length of study is provided as input. The approach first
use backdoor adjustment to create sample data from experimental study, and
then compute the hazard ratio from the sampled experimental data.
4.1. Assumptions
We assume a simple observational study for a population, consisting of treatment X, con-
founding variable Z, and outcome in survival time T . In this scenario, treatment X is a
dichotomous variable (X = 1 signifying treatment and X = 0 signifying control). Outcome
T is the survival time from the beginning of the study and is a continuous variable in time
units. Although the confounding variables can be a categorical or continuous variable, for
simplicity, we assume the confounder Z to be a dichotomous variable. This observational
study can be expressed as an SCM and with a graphical form G through causal directed
acyclic graph (causal DAG) in Figure 2, where treatment, confounder, and outcome is
expressed by the nodes X, Z and T respectively.
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Figure 2: Simple observational study treatment X, outcome in survival-time T and sin-
gle confounder Z, expressed using causal directed acyclic graph (nodes are the
variables, edges portray causal relationships between variables)
From the definition of the SCM, we can express the underlying functions defining the
causal relationships between variables by: Z ← fz(Uz), X ← fx(Z,Ux), T ← ft(Z,X,Ut, h0(t)).
Here, U = {Ux, Ut, Uz} is the set of exogenous variables, V = {Z,X, T} is the set of en-
dogenous variables, f = {fz, fx, ft} is the set of structural functions.
• fz(Uz) shows that confounder Z is independent of any other endogenous variables.
• fx(Z,Ux) expresses the dependency ofX on Z. Since Z is parameter for both functions
fx and fy, Z imposes a bias on the model (P (X|Z = 0) 6= P (X|Z = 1)), and the
function fx defines whether the bias is strong or weak.
• ft(Z,X,Ut, h0(t)) defines the effect of X and Z on the survival time T . This function
also depends on the baseline hazard function h0(t,X) since this defines the rate of
decline in survival.
We also assume to know the sample size of population n and a maximum length of survival
time tmax.
4.2. Approach
4.2.1. Transformation of single study to multiple studies
Experimental studies commonly have different study time-lengths, e.g., different number of
days as the outcome endpoints (e.g., 30-day survival, 90-day survival, etc.). This variable is
a dichotomous variable and describes a patients’ status of survival at the end of the study.
While analyzing a study similar to these, we do not take into account survival at each day,
or survival after end-of-trial day, since we do not have the opportunity to do so. In our
problem definition, we only have the survival time of individuals; however there is no defined
end time for the trial. From the individual survival time, We can easily get the i-th day
survival of every individual in the dataset, i being the number of days from the beginning
of the study. We use days as smallest unit of time, since we assume the dataset reports
survival in units of days. However, it could be any other units of times (e.g. minutes, or
weeks) depending on the problem domain and dataset.
Since our observational study has a maximum survival time of all individuals tmax, we
assume we calculate the variables Yi, signifying the i-th day survival, i ranging from 0 to
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tmax. Conversion of continuous variable T describing survival time into multiple variables
Yi, each describing survival at the i-th day, essentially breaks down the single observational
study into tmax number of observational studies with variables X, Z and Yi, each of which
is now a dichotomous variable.
Through the transformation, from a single SCM G, we end up with n different SCMs,
each with the same treatment X and the confounder Z, but different outcome (survival
at i-th day). Note that, in our assumption, the causal graph is time-invariant, i.e., the
functional relationship between the variables does not change over time. This conversion is
represented by n different SCMs (Transformed graphs A, Figure 3 (a)), where n ≥ tmax.
An important point to note here is that, the single confounder Z and treatment X from
the original observational study is not being transformed, only the outcome is distributed
into multiple variables. In other words, we assume a point intervention and the confounding
variables are invariant in time. And since we are transforming from a single trial to multiple
trials, the outcomes Yis of these separate trials are not conditionally dependent on each other
(e.g. a RCT with 30-day survival as outcome does not analyze about whether any patient
died at 20th day or 29th day.).
However, in extracting information from obs. data, there is dependency between them.
Specifically, Yi has causal effect on Yj (where j > i), since if Yi is 0 (e.g. patient died at i-th
day), all Yj (where j > i) is 0 (e.g. patient remains dead for all consecutive days). Also, Yi
only has direct causal effect on Yi+1, every other corresponding effect is mediated through.
If X has causal effect on Yi, it is mediated through Yi−1. For example, X ⊥ Y1|Y0, in
absence of any backdoor variables. The relationship between Yis is reflected through a single
transformed SCM (Transformed graph B, Figure 3 (b)), where n ≥ tmax. The similarities
between transformed graphs A and transformed graph B is that they both have same Z
and X, and the dissimilarities are:
1. Transformed graphs A portrays n different trials with different outcomes, whereas
transformed graph B is a single trial.
2. For transformed graphs A, Yi ⊥ Yj (where j 6= i), however for transformed graph B,
Yi 6⊥ Yj (where j 6= i).
3. Since two causal DAGs are different, transformed graphs A and transformed graph B
have two different equations for P (Yi|do(X)).
In summary, we transform the single observational study into multiple different trials
expressed through two different transformations (transformed graphs A and transformed
graph B, Figure 3), each with the same treatment X and confounding Z, but with different
survival time as the outcomes, as the death (or failure) increases over time. These outcomes
are the status of survival (or death) at i-th day, where i is 0 to n (n ≥ tmax).
4.2.2. Generation of Survival Curve
Applying Backdoor adjustment formula in transformed graphs A, the causal effect of X on
Yi (for all n causal graphs) is:
P (Yi|do(X)) =
∑
Z
P (Yi|X,Z)P (Z)
10
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For outcome Y0 For outcome Y1 For outcome Yn
(a) Converted Causal DAGs with no dependency between Yis
(b) Converted single Causal DAG with dependencies between Yis
Figure 3: Converted Causal DAGs with survival time converted to binary outcome of sur-
vival at different timepoints
In transformed graph B, the causal effect of X on Yi is:
P (Yi|do(X)) =
∑
Z,Yi−1,...Y1,Y0
(
n∏
k=0
P (Yk|Yk−1, ..., Y0, X, Z)
)
· P (Z)
Since P (A|B,C)P (B|C) = P (A,B|C) (using rules of conditional probabilities), we can
reduce this equation to,
P (Yi|do(X)) =
∑
Z,Yi−1,...Y1,Y0
P (Yi, Yi−1, ..., Y0|X,Z)P (Z)
Finally, for j <= i, P (Yj = 1|Yi = 1) = 1 (e.g. if a person is alive at 30th day, he has been
alive for the last 29 days as well), P (Yi = 1, Yi−1 = 1) = P (Yi−1 = 1|Yi = 1)P (Yi = 1) =
P (Yi = 1), which reduces our equation down to the same as that of transformed graphs A:
P (Yi = 1|do(X)) =
∑
Z
P (Yi = 1|X,Z)P (Z)
This signifies whether we use transformed graphs A or transformed graph B, we end up
with same adjustment formula.
For each of the newly transformed causal DAGs, we can now adjust for the confounder
using the backdoor adjustment formula. We calculate adjusted probabilities Padj and thus
adjusted counts Cadj for each of the n causal graphs. Using the values of Padj , we generate
survival curve with Kaplan Meier fitter.
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Algorithm 1 Causally Formulated Hazard Ratio Estimation
Input: Z, X, T , S
Output: survival curve, HRdrug
1: global n← length(T )
2: global tmax ← max(T )
3: Yi ← convert single to multiple trials(T, S)
4: for i← 0 to tmax do
5: adj pi ←
∑
Z P (Yi = 1 |X,Z)P (Z)
6: adj ci ← adj pi ∗ count(X)
7: end for
8: survival curve← plot(time, cumulative(adj pi))
9: adj X, adj T ← convert multiple to single trial(adj ci)
10: model← cox ph model(adj X, adj T )
11: HRdrug ← exp(model.βdrug)
12: return survival curve,HRdrug
Algorithm 2 Conversion of single trial to multiple trials
Input: T , S
Output: Yi
1: for i← 0 to tmax do
2: for j ← 0 to n do
3: Yi[j]← (T [j] <= i) and (S[j] = 1) ? 0 : 1
4: end for
5: end for
6: return Yi
4.2.3. Calculation of Hazard Ratio
Since we calculated Cadj for each of n causal graphs, we know number of adjusted individuals
alive at each unit (day) of time. This helps us build back the adjusted survival time Tadj
for individuals, as it was in the original dataset. The newly calculated survival time Tadj is
adjusted for the confounding bias, as if they were sampled from an RCT. We measure the
HR using Cox PH model with the adjusted survival time Tadj as outcome.
4.2.4. Algorithm
Algorithm 1 generates adjusted Kaplan Meier curve as well as the HR from Cox PH model on
the adjusted dataset. The input for the algorithm is the dataset, specifically, confounder Z,
treatment X, survival time T , and event status S. In the algorithm, variables in uppercase
letters signify vectors, and variables in lowercase signify single variables. Internal procedures
convert single to multiple trials (Algorithm 2) are shown separately.
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5. Experiments and Applications
We evaluated the proposed approach for computing HR and visualizing survival curves
with an experimental and observational dataset: (1) a synthetic dataset derived from a
linear acyclic model with Gaussian noise; (2) a real-world dataset on disease-free survival in
patients with Ewing’s Sarcoma (Makuch, 1982). The rationale to consider these two datasets
are: (1) both of the underlying causal model has a backdoor path through confounders, and,
(2) both these datasets have treatment and control group that satisfy the proportionality
hazarads assumption.
5.1. Experimental Data
We simulate an observational study with n = 200 patients. A subgroup of the patients
received a treatment (X = 1), and the remaining patients did not (X = 0). We generate
data on survival time T (in days) defined as the outcome. The treatment assignment is
confounded by sex (e.g. Z = 1 for female, Z = 0 for others). The scenario has a causal
model as depicted in Figure 2.
For the simulation, we generated outcome variable survival-time through defining a
baseline hazard function. We defined survival time to be exponentially varying with time,
in the form of: T ← a.exp((b+ cZ+dX+ eZX)∗ i) +E, with Z being confounder, X being
treatment, E being the noise/error and i being the index of patient. The other parameters
were set to a = 5, b = 0.025, c = 0.005, d = −0.015, e = 0.075, E = U(−0.5, 0.5), they were
selected such that the HR remains close to 1, however injection of bias through Z portrays
different outcome in survival curve.
We simulate the study with a strong biased effect from confounder Z. We define the
strength of bias by an imbalance of conditional probabilities in each stratum of Z through
the function fx(Z,Ux). For the defined strong bias case, P (X = 1|Z = 0) = 0.75 and
P (X = 1|Z = 1) = 0.25. It translates to, if Z = 0 stands for females in this trial, 75%
received the drug, whereas, in Z = 1 or others, only 25% received the drug. In a randomized
controlled trial, under a no-confounding-bias scenario, we should have P (X = 1|Z = 0) =
P (X = 1|Z = 1) = 0.5.
After we generate the experimental data, we applied Algorithm 1. We compared the
existing approach of survival curve and survival curve from the adjusted dataset side-by-side
in Figure 4.
Table 1 presents the HR found in the fitted Cox PH model in three different processes:
1. using only the treatment and outcome from the original dataset,
2. using data of all covariates (treatment, outcome and confounder) from the original
dataset, and
3. using only the treatment and outcome from the adjusted dataset following our pro-
posed approach.
The first approach represents scenarios where: 1) we ignore confounding, assuming it
does not impact the treatment, or, 2) we do not possess data on the confounding variable
(unmeasured confounding). This approach, however, results in an incorrect approximation
of the HR. The second approach represents the existing approach to calculate HR. The
13
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Figure 4: Unadjusted survival curve for simulated data (left) and, survival curve generated
after applying proposed approach (right). Figure on left shows significant dif-
ference in survival curve between treatment and control group. The treatment
population (X = 1) seems to be more prone to hazard compared to the control
population (X = 0). Figure on right shows adjusted survival curve to be over-
lapping, signifying no significant difference in hazard rate in both the treatment
and the control population.
third one shows our approach, and it eliminates the need for using confounding in model
fitting since we are already adjusting for that.
Here, in Figure 4, the difference in unadjusted survival curve is similar to fitting Cox PH
model with only X and T , leaving out Z, as found following the first approach generating
HR=1.66. On the other hand, the overlapping adjusted survival curve is validated by
calculated HR, following both the existing approach with the Cox PH model (HR=0.8) and
our algorithm (HR=1.0).
5.2. Ewing’s Sarcoma Data
We also applied the proposed method to a real-world dataset of patients with Ewing’s
Sarcoma (Makuch, 1982). The dataset was selected based on its survival data and known
Existing model Proposed model
Observational data
excluding confounding variable
(biased estimate)
Observational data
including confounding variable
(traditional approach)
Transformed and adjusted data
Hazard Ratio 1.66 0.08 1.00
(95% Confidence Interval) (1.25-2.20) (0.57-1.12) (0.76-1.33)
Table 1: Hazard Ratio for simulated dataset, calculated using existing model and our pro-
posed approach. 1st column reports a biased estimate of HR, by using only treat-
ment and outcome (excluding confounder) in Cox PH model. The second column
reports a standard estimate of HR, by including all known variables (including
confounder). The third column reports HR calculated in our proposed approach,
using only treatment and outcome (excluding confounder).
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Figure 5: Unadjusted survival curve for Ewing dataset (left) and, survival curve generated
after applying proposed approach (right). Figure on left presents treatment group
(X = 1) to be less hazardous than control group (X = 0). Figure on right is the
adjusted survival curve with mostly overlapping survival curves of two groups,
although treatment group (X = 1) seems slightly more prone to hazards.
causal DAG consisting of confounders. The dataset consists of a total of 76 Ewings sarcoma
patients with disease-free survival days as the outcome. 47 of the patients received a novel
treatment (S4), and 29 received (one of) three (S1S3) standard treatments.
The level of Serum lactic acid dehydrogenase (LDH) acted as the confounder, since high
LDH levels indicated a lesser likelihood of treatment assignment along with an impact on
survival time. In our analysis, we marked patients receiving S4 as the treatment group
(X = 1) and patients receiving S1-S3 as the control group (X = 0). We applied our
algorithm on this data set and the survival curve with the existing approach. Results of
our algorithm is shown in Figure 5. The adjusted survival curve shows similar results, as
demonstrated in Makuch et al. (Makuch, 1982). We also present the calculated HR following
Existing model Proposed model
Observational data
excluding confounding variable
(biased estimate)
Observational data
including confounding variable
(traditional approach)
Transformed and adjusted data
Hazard Ratio 0.53 1.12 1.04
(95% Confidence Interval) (0.30-0.96) (0.59-2.11) (0.57-1.87)
Table 2: Hazard Ratio for Ewing dataset, calculated using existing model and our proposed
approach. The first column reports a biased estimate of the HR based on only
the treatment and outcome (excluding confounder) in Cox PH model. The second
column reports a standard estimate of the HR that includes all known variables
(including the confounder(s)). The third column reports the HR calculated in
our proposed approach, using only the treatment and outcome (excluding the
confounder). The reason for getting an accurate estimate of the HR even when
excluding the confounder is because we adjusted the dataset beforehand using a
minimum set of confounders from the SCM, thus focusing on the true causal effect
of treatment on outcome.
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Figure 6: Two example graphs where the backdoor adjustment will produce different results
compared to an approach based on the ignorability assumption. In the left hand
side, X is the treatment, Y is the mediator, and M is a mediator. For the second
graph, Z acts as a confounder as well. The left hand side is the example of a
mediator and the right hand side graph is known as the front-door setting.
the three processes described in the earlier subsection. In Table 2, the HR calculated by
our approach (HR=1.04) differs from the HR calculated in the traditional way (HR=1.12),
presenting the drug to be a little less hazardous. However, the 95% confidence interval for
both of these coincide, signifying that the true value lies within this range.
6. Discussion and Conclusion
We propose a novel method to estimate the HR using the Cox PH Model through the
transformation of observational data to corresponding experimental data leveraging an un-
derlying SCM. The transformed data are mathematically guaranteed to be adjusted for
the confounding bias with the assumption that the SCM represents the data generating
mechanism. Previous approaches under RCM that estimate the survival curve use the ig-
norability assumption, and will not work when the variables selected do not satisfy the back-
door criterion. Ignorability assumption states that, distribution of the potential outcomes
(Y (0), Y (1)) is independent of the treatment variable by randomly assigning treatment:
{Y (0), Y (1)} ⊥ X. An extension of the idea, conditional ignorability states, distribution
of the potential outcomes (Y (0), Y (1)) is independent of the treatment variable (X), con-
ditional on the covariates (Z): {Y (0), Y (1)} ⊥ X|Z. Using conditional ignorability for
adjustment on covariates allowed researchers to draw inferences from observational stud-
ies as well; however, adjusting all covariates irrespective of their causal relationship with
treatment and outcome can contribute more bias to the model and incorrect estimation of
causal effects.
We present two scenarios as example in Figure 6. In the first scenario (Figure 6, left),
we show an SCM with treatment X and outcome Y with a third covariate M . Here M acts
as a mediator in between X and Y , thus the backdoor adjustment gives a null set, mean-
ing no adjustment is needed. The do-calculus formula would be: P (Y |do(X)) = P (Y |X).
Adjusting on M based on conditional ignorability will produce an incorrect estimation of
causal effect. In the second scenario (Figure 6, right), we discuss a setting called front-door
adjustment where we identify the variables to be adjusted with two applications of back-
door adjustment Pearl (2009). In an SCM with a mediator (shown in Figure 6 (right)),
the covariate M does not satisfy the backdoor criterion and acts as a mediator between
16
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treatment X and outcome T . Thus, adjusting with M irrespective of its role as media-
tor will produce a biased estimate of the HR. The accurate backdoor adjustment formula
(with M as mediator) is P (Y |do(X)) = ∑M P (M |X)∑X P (Y |X,M)P (X). However, ad-
justment by assuming M (and Z) as confounder gives an incorrect adjustment formula:
P (Y |do(X)) = ∑M,Z P (Y |M,X,Z)P (Z)P (M). Our approach (with backdoor criterion)
can correctly identify the variables to be adjusted for estimating HR using SCM and do-
calculus.
Both the survival curve and the HR help to build a strong interpretation of the survival
analysis of an experiment. The HR is most frequently reported as it summarizes the overall
effect of treatment. However, survival curve encodes information on changes in survival
over time (Herna´n, 2010), which, in certain cases gives us better insight. Our proposed
method is capable of generating both the survival curve and the HR, along with proper
backdoor adjustment based on the underlying SCM. The HR calculated from the adjusted
dataset requires only the treatment and outcome variables, and thus relies on direct causal
relationships of treatment and outcome. For this purpose, we assume knowledge of the true
causal model, an absence of unmeasured confounders, functional relationship in the SCM
being time-invariant, and, proportionality of the HR in the outcome. In reality, defining
the causal graph with SCM, that is, causal structure learning, requires a principled ap-
proach. The development of statistical and computational algorithms for causal structure
learning is an active research area (Heinze-Deml et al., 2018; Rottman and Keil, 2012), and,
is not well-established in the current literature. We are currently working on a methodolog-
ical framework to develop the causal graph with structure learning algorithm and domain
expertise.
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